Fig. 1From: Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemiaSurvival outcome A overall, B by treatment modality, C by Salvage status, D by best MRD status, E by allogeneic stem cell transplantation, and F in comparison with inotuzumab monotherapy. S1 Salvage 1; S2 + Slavage 2 and beyond; Neg Negative; Pos Positive; Ino Inotuzumab; Blina Blinatimomab; Rtx RituximabBack to article page